Home › Funds › Frazier Life Sciences Management, L.P. › MIRM

Frazier Life Sciences Management, L.P. position in MIRM

MIRUM PHARMACEUTICALS INC · Health Care

Frazier Life Sciences Management, L.P. reported holding 7,679,684 shares of MIRM (MIRUM PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$899.1M, representing 19.58% of its reported portfolio and ranking #1 among its reported holdings. Frazier Life Sciences Management, L.P. has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)7.68M sh
Reported value held$899.06M
Portfolio Weight19.58%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Frazier Life Sciences Management, L.P.'s MIRM position evolved

Frazier Life Sciences Management, L.P. first disclosed a stake in MIRM in Q3 2023 at 6,470,392 shares (US$204.5M). The position peaked in Q2 2026 at 7,679,684 shares, worth US$899.1M. Across 12 filings, Frazier Life Sciences Management, L.P. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 7,679,684 shares valued at US$899.1M.

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.47M $204.46M New
Q4 2023 6.50M $191.74M Hold
Q1 2024 6.50M $163.16M Hold
Q2 2024 6.50M $222.08M Hold
Q3 2024 6.57M $256.25M Add
Q4 2024 6.57M $271.69M Hold
Q1 2025 6.80M $306.12M Add
Q2 2025 6.80M $345.80M Hold
Q3 2025 6.80M $498.15M Hold
Q4 2025 6.80M $536.75M Hold
Q1 2026 7.68M $709.45M Add
Q2 2026 7.68M $899.06M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIRM and 13F data

MIRM (MIRUM PHARMACEUTICALS INC) is a Health Care company. 61 other funds we track also report a position in MIRM — the largest reported positions include EVENTIDE ASSET MANAGEMENT, LLC (US$146.2M), TANG CAPITAL MANAGEMENT LLC (US$144.7M), Novo Holdings A/S (US$131.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIRM

All MIRM fund holders →

FAQ

How long has Frazier Life Sciences Management, L.P. held MIRM?

Frazier Life Sciences Management, L.P. has disclosed MIRM holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Frazier Life Sciences Management, L.P.'s current position in MIRM?

As of Q2 2026, Frazier Life Sciences Management, L.P. holds 7.68M shares of MIRM (MIRUM PHARMACEUTICALS INC), valued at $899.06M, representing 19.58% of its reported portfolio and ranking #1.

Has Frazier Life Sciences Management, L.P. been buying or selling MIRM?

In the latest 13F filing (Q2 2026), Frazier Life Sciences Management, L.P. held unchanged its position in MIRM. The position peaked in Q2 2026 at 7.68M shares.

Which other funds hold MIRM?

Other major institutional holders of MIRM include EVENTIDE ASSET MANAGEMENT, LLC, TANG CAPITAL MANAGEMENT LLC, Novo Holdings A/S, among 61 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.